YBX1 and non-small cell lung carcinoma: Moreover, Kaplan‐Meier analysis revealed that the OS rate was significantly lower for NSCLC patients with high expression of YB1, but it was not a significant prognosis factor in multivariate analysis, which needs to be further investigated.